Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Aspirin Use is Associated with Decreased Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis

Pramod Savarapu, Nischit Baral, Govinda Adhikari, Maxwell Akanbi, Basel Abdelazeem, Sakiru O. Isa, Ashiya Khan, Maham Ali, Sravanthi Jenumula, Kavitha Kesari, Arvind Kunadi
doi: https://doi.org/10.1101/2021.07.08.21260236
Pramod Savarapu
1Internal Medicine, Mclaren Flint/MSU
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nischit Baral
2Resident, Internal Medicine, Mclaren Flint/MSU
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: baralnis@msu.edu nischit.baral@mclaren.org
Govinda Adhikari
1Internal Medicine, Mclaren Flint/MSU
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maxwell Akanbi
1Internal Medicine, Mclaren Flint/MSU
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Basel Abdelazeem
1Internal Medicine, Mclaren Flint/MSU
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sakiru O. Isa
1Internal Medicine, Mclaren Flint/MSU
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashiya Khan
1Internal Medicine, Mclaren Flint/MSU
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maham Ali
1Internal Medicine, Mclaren Flint/MSU
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sravanthi Jenumula
1Internal Medicine, Mclaren Flint/MSU
MD
Roles: Clinical Observer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kavitha Kesari
3Faculty, Internal Medicine, Mclaren Flint/MSU
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arvind Kunadi
3Faculty, Internal Medicine, Mclaren Flint/MSU
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Novel Corona Virus Disease 2019 (COVID-19) has resulted in more than three and half million deaths worldwide as of June 6, 2021. The role of aspirin in prevention of COVID-19 mortality has not been much studied. We aimed to study the relationship between aspirin use and covid-19 mortality.

Methods We searched PubMed, MEDLINE, EMBASE, and Cochrane database for studies from January 2019 till June 6, 2021 with inclusion criteria of RCT, Cohort study, studies reporting mortality, and comparison studies on aspirin versus non-aspirin. Statistical analysis was done with Review Manager 5.4 statistical software using the inverse variance method. We assessed the pooled hazard ratio (HR), and 95% confidence interval using the random effect model and I-squared test was used to determine statistical heterogeneity.

Results We included five retrospective cohort studies which met our inclusion criteria with total of 14065 participants in both groups. There were 6797 participants in the aspirin group and 7268 participants in the non-aspirin group. Our results show that the use of aspirin was associated with 53% decrease in mortality compared to non-aspirin in patients with COVID-19 (adjusted HR 0.47, 95% CI 0.35-0.63, P< 0.001, I2= 47%). In the analysis restricted to patients hospitalized for COVID-19, the use of aspirin was associated with a 49% reduction in the risk for in-hospital mortality (adjusted HR 0.51, 95% CI 0.33-0.80, P = 0.004, I2= 39%).

Conclusions Our results show that aspirin is associated with decrease in both overall mortality and in-hospital mortality in patients with COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

It is a systematic review and meta-analysis

Funding Statement

None

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Use of secondary data from published literature.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • FUNDING: NONE

  • DISCLOSURE: All the authors have no relationships relevant to the contents of this paper to disclose

Data Availability

The link of secondary data are on the references of the manuscript.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted July 10, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Aspirin Use is Associated with Decreased Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Aspirin Use is Associated with Decreased Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis
Pramod Savarapu, Nischit Baral, Govinda Adhikari, Maxwell Akanbi, Basel Abdelazeem, Sakiru O. Isa, Ashiya Khan, Maham Ali, Sravanthi Jenumula, Kavitha Kesari, Arvind Kunadi
medRxiv 2021.07.08.21260236; doi: https://doi.org/10.1101/2021.07.08.21260236
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Aspirin Use is Associated with Decreased Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis
Pramod Savarapu, Nischit Baral, Govinda Adhikari, Maxwell Akanbi, Basel Abdelazeem, Sakiru O. Isa, Ashiya Khan, Maham Ali, Sravanthi Jenumula, Kavitha Kesari, Arvind Kunadi
medRxiv 2021.07.08.21260236; doi: https://doi.org/10.1101/2021.07.08.21260236

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (141)
  • Cardiovascular Medicine (1955)
  • Dentistry and Oral Medicine (253)
  • Dermatology (186)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (702)
  • Epidemiology (11118)
  • Forensic Medicine (8)
  • Gastroenterology (629)
  • Genetic and Genomic Medicine (3192)
  • Geriatric Medicine (309)
  • Health Economics (565)
  • Health Informatics (2048)
  • Health Policy (864)
  • Health Systems and Quality Improvement (788)
  • Hematology (310)
  • HIV/AIDS (684)
  • Infectious Diseases (except HIV/AIDS) (12738)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (318)
  • Medical Ethics (92)
  • Nephrology (336)
  • Neurology (2999)
  • Nursing (165)
  • Nutrition (465)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1560)
  • Ophthalmology (478)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (914)
  • Pharmacology and Therapeutics (382)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2795)
  • Public and Global Health (5609)
  • Radiology and Imaging (1100)
  • Rehabilitation Medicine and Physical Therapy (635)
  • Respiratory Medicine (764)
  • Rheumatology (340)
  • Sexual and Reproductive Health (314)
  • Sports Medicine (289)
  • Surgery (347)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)